Our mission is to find a cure for leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms, as well as to improve the quality of life for people impacted by a blood cancer. LLSC has awarded more than $23 million in blood cancer research funding since 1995.
